Julian Harrison

Contact Us

Julian Harrison is a Director and BTIG Biotechnology Analyst. Prior to BTIG, he was an Equity Research Associate at H.C. Wainwright & Co., covering small- to mid-cap biotechnology and specialty pharmaceutical companies. Previously, Mr. Harrison was a Clinical and Translational Research Assistant at Hospital for Special Surgery. He earned a BS in biology from Cornell University and an MS in health economics from Weill Cornell Medical College.


Coverage Area

Company Ticker
Aclaris Therapeutics ACRS
MoonLake Immunotherapeutics MLTX
CymaBay Therapeutics CBAY
United Therapeutics Corporation UTHR
Matinas BioPharma Holdings, Inc. MTNB
Protagonist Therapeutics, Inc. PTGX
Biora Therapeutics, Inc. BIOR
Rani Therapeutics Holdings, Inc. RANI
Aura Biosciences, Inc. AURA
Aerovate Therapeutics AVTE
Morphic Therapeutic MORF
Liquidia Corporation LQDA
Keros Therapeutics KROS
Outlook Therapeutics OTLK
Viridian Therapeutics VRDN